Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

241 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A Phase I-II multicenter trial with Avelumab plus autologous dendritic cell vaccine in pre-treated mismatch repair-proficient (MSS) metastatic colorectal cancer patients; GEMCAD 1602 study.
Español-Rego M, Fernández-Martos C, Elez E, Foguet C, Pedrosa L, Rodríguez N, Ruiz-Casado A, Pineda E, Cid J, Cabezón R, Oliveres H, Lozano M, Ginés A, García-Criado A, Ayuso JR, Pagés M, Cuatrecasas M, Torres F, Thomson T, Cascante M, Benítez-Ribas D, Maurel J. Español-Rego M, et al. Among authors: maurel j. Cancer Immunol Immunother. 2023 Apr;72(4):827-840. doi: 10.1007/s00262-022-03283-5. Epub 2022 Sep 9. Cancer Immunol Immunother. 2023. PMID: 36083313 Free PMC article.
[Evaluation of the efficacy and efficiency of a multidisciplinary unit for the treatment of patients with colorectal cancer].
Soriano A, Castells A, Lacy AM, Ayuso C, Ayuso JR, Conill C, Delgado S, Fuster J, García-Valdecasas JC, Ginès A, Martín M, Maurel J, Miquel R, Mollà M, Vilana R, Castellví-Bel S, Elizalde JI, Piñol V, Pellisé M, Biete A, Gascón P, Piqué JM. Soriano A, et al. Among authors: maurel j. Gastroenterol Hepatol. 2002 Dec;25(10):579-84. doi: 10.1016/s0210-5705(02)70319-1. Gastroenterol Hepatol. 2002. PMID: 12459118 Spanish.
Phase I trial of neoadjuvant chemoradiotherapy (CRT) with capecitabine and weekly irinotecan followed by laparoscopic total mesorectal excision (LTME) in rectal cancer patients.
Ugidos L, Delgado S, Conill C, Ginés A, Gallego R, Ayuso JR, Miquel R, Tosca M, de Lacy A, Castells A, Maurel J. Ugidos L, et al. Among authors: maurel j. Invest New Drugs. 2009 Jun;27(3):262-8. doi: 10.1007/s10637-008-9192-6. Epub 2008 Oct 16. Invest New Drugs. 2009. PMID: 18923810 Clinical Trial.
Imatinib plus low-dose doxorubicin in patients with advanced gastrointestinal stromal tumors refractory to high-dose imatinib: a phase I-II study by the Spanish Group for Research on Sarcomas.
Maurel J, Martins AS, Poveda A, López-Guerrero JA, Cubedo R, Casado A, Martínez-Trufero J, Ramón Ayuso J, Lopez-Pousa A, Garcia-Albeniz X, Garcia del Muro X, de Alava E. Maurel J, et al. Cancer. 2010 Aug 1;116(15):3692-701. doi: 10.1002/cncr.25111. Cancer. 2010. PMID: 20564079 Free article. Clinical Trial.
[Incidence and characteristics of pancreatic cystic neoplasms].
Adet A, Miquel R, Bombi JA, Gines A, Fernández-Esparrach G, De Juan C, Ayuso JR, Maurel J, Castells A, Fernández-Cruz L, Navarro S. Adet A, et al. Among authors: maurel j. Gastroenterol Hepatol. 2010 Oct;33(8):563-8. doi: 10.1016/j.gastrohep.2010.07.001. Epub 2010 Sep 20. Gastroenterol Hepatol. 2010. PMID: 20850905 Spanish.
Co-expression of matrix metalloproteinase-7 (MMP-7) and phosphorylated insulin growth factor receptor I (pIGF-1R) correlates with poor prognosis in patients with wild-type KRAS treated with cetuximab or panitumumab: a GEMCAD study.
Hörndler C, Gallego R, García-Albeniz X, Alonso-Espinaco V, Alonso V, Escudero P, Jimeno M, Ortego J, Codony-Servat J, Fernández-Martos C, Calatrava A, Marín-Aguilera M, Muñoz J, Castellví-Bel S, Castells A, Rubini M, Gascón P, Maurel J. Hörndler C, et al. Among authors: maurel j. Cancer Biol Ther. 2011 Jan 15;11(2):177-83. doi: 10.4161/cbt.11.2.13839. Epub 2011 Jan 15. Cancer Biol Ther. 2011. PMID: 21099348 Free article.
Serum matrilysin correlates with poor survival independently of KRAS and BRAF status in refractory advanced colorectal cancer patients treated with irinotecan plus cetuximab.
Garcia-Albeniz X, Pericay C, Alonso-Espinaco V, Alonso V, Escudero P, Fernández-Martos C, Gallego R, Gascón P, Castellví-Bel S, Maurel J. Garcia-Albeniz X, et al. Among authors: maurel j. Tumour Biol. 2011 Apr;32(2):417-24. doi: 10.1007/s13277-010-0136-3. Epub 2010 Nov 23. Tumour Biol. 2011. PMID: 21104178
Design and endpoints of clinical and translational trials in advanced colorectal cancer. a proposal from GROUP Español Multidisciplinar en Cancer Digestivo (GEMCAD).
Carrera G, Garcia-Albeniz X, Ayuso JR, Aparicio J, Castells A, Codony-Servat J, Feliu J, Fuster D, Gallego R, Pagés M, Torres F, Maurel J. Carrera G, et al. Among authors: maurel j. Rev Recent Clin Trials. 2011 May;6(2):158-70. doi: 10.2174/157488711795177868. Rev Recent Clin Trials. 2011. PMID: 21241233 Review.
[Malignancy predictive factors in pancreatic intraductal papillary mucinous neoplasm].
Adet Caldelari AC, Miquel R, Bombi JA, Ginés A, Fernández-Esparrach G, Ayuso JR, Maurel J, Feu F, Castells A, Fernández-Cruz L, Navarro S. Adet Caldelari AC, et al. Among authors: maurel j. Med Clin (Barc). 2011 Nov 26;137(14):631-6. doi: 10.1016/j.medcli.2010.11.026. Epub 2011 Mar 16. Med Clin (Barc). 2011. PMID: 21414642 Spanish.
241 results